These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 12934182

  • 1. Pulmonary immunoglobulin responses to Streptococcus pneumoniae are altered but not reduced in human immunodeficiency virus-infected Malawian adults.
    Gordon SB, Miller DE, Day RB, Ferry T, Wilkes DS, Schnizlein-Bick CT, Zijlstra EE, Read RC, Molyneux ME, Twigg HL.
    J Infect Dis; 2003 Sep 01; 188(5):666-70. PubMed ID: 12934182
    [Abstract] [Full Text] [Related]

  • 2. HIV-1 infection is associated with altered innate pulmonary immunity.
    Gordon SB, Janoff EN, Sloper D, Zhang Q, Read RC, Zijlstra EE, Finn A, Molyneux ME.
    J Infect Dis; 2005 Oct 15; 192(8):1412-6. PubMed ID: 16170759
    [Abstract] [Full Text] [Related]

  • 3. Decreased serum opsonic activity against Streptococcus pneumoniae in human immunodeficiency virus-infected Ugandan adults.
    Takahashi H, Oishi K, Yoshimine H, Kumatori A, Moji K, Watanabe K, Nalwoga H, Tugume SB, Kebba A, Mugerwa R, Mugyenyi P, Nagatake T.
    Clin Infect Dis; 2003 Dec 01; 37(11):1534-40. PubMed ID: 14614677
    [Abstract] [Full Text] [Related]

  • 4. A pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased VH3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected persons.
    Chang Q, Abadi J, Alpert P, Pirofski L.
    J Infect Dis; 2000 Apr 01; 181(4):1313-21. PubMed ID: 10762563
    [Abstract] [Full Text] [Related]

  • 5. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy.
    D'Orsogna LJ, Krueger RG, McKinnon EJ, French MA.
    AIDS; 2007 Aug 20; 21(13):1747-52. PubMed ID: 17690573
    [Abstract] [Full Text] [Related]

  • 6. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients.
    Huo Z, Spencer O, Miles J, Johnson J, Holliman R, Sheldon J, Riches P.
    Vaccine; 2004 Mar 12; 22(9-10):1157-61. PubMed ID: 15003643
    [Abstract] [Full Text] [Related]

  • 7. Lung fluid immunoglobulin from HIV-infected subjects has impaired opsonic function against pneumococci.
    Eagan R, Twigg HL, French N, Musaya J, Day RB, Zijlstra EE, Tolmie H, Wyler D, Molyneux ME, Gordon SB.
    Clin Infect Dis; 2007 Jun 15; 44(12):1632-8. PubMed ID: 17516409
    [Abstract] [Full Text] [Related]

  • 8. A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults.
    French N, Moore M, Haikala R, Kayhty H, Gilks CF.
    J Infect Dis; 2004 Aug 15; 190(4):707-12. PubMed ID: 15272398
    [Abstract] [Full Text] [Related]

  • 9. Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virus.
    King JC, Borkowsky W, Mahidhara N, Madore D, Shapiro ED, Rutstein RM, Tan TQ, Farley JJ, Dankner WM, Nachman S, Simoes E, Flynn PM, Clemens J, Hamilton RG.
    J Infect Dis; 2000 May 15; 181(5):1817-21. PubMed ID: 10823792
    [Abstract] [Full Text] [Related]

  • 10. Serum concentrations of pneumococcal anticapsular antibodies in children with pneumonia associated with Streptococcus pneumonia infection.
    Esposito S, Droghetti R, Faelli N, Lastrico A, Tagliabue C, Cesati L, Bianchi C, Principi N.
    Clin Infect Dis; 2003 Nov 01; 37(9):1261-4. PubMed ID: 14557973
    [Abstract] [Full Text] [Related]

  • 11. Opsonic phagocytosis of Streptococcus pneumoniae by alveolar macrophages is not impaired in human immunodeficiency virus-infected Malawian adults.
    Gordon SB, Molyneux ME, Boeree MJ, Kanyanda S, Chaponda M, Squire SB, Read RC.
    J Infect Dis; 2001 Nov 15; 184(10):1345-9. PubMed ID: 11679928
    [Abstract] [Full Text] [Related]

  • 12. Opsonic function of bronchoalveolar lavage IgG after pneumococcal vaccination in HIV-infected and uninfected adults.
    Tam JC, Grant NL, Freire-Moran L, Tolmie H, French N, Gordon SB.
    J Allergy Clin Immunol; 2009 Jun 15; 123(6):1420-1. PubMed ID: 19423153
    [No Abstract] [Full Text] [Related]

  • 13. Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapy.
    Subramaniam KS, Segal R, Lyles RH, Rodriguez-Barradas MC, Pirofski LA.
    J Infect Dis; 2003 Mar 01; 187(5):758-68. PubMed ID: 12599049
    [Abstract] [Full Text] [Related]

  • 14. Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection.
    Abadi J, Pirofski La.
    J Infect Dis; 1999 Sep 01; 180(3):915-9. PubMed ID: 10438394
    [Abstract] [Full Text] [Related]

  • 15. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana.
    Shapiro RL, Lockman S, Kim S, Smeaton L, Rahkola JT, Thior I, Wester C, Moffat C, Arimi P, Ndase P, Asmelash A, Stevens L, Montano M, Makhema J, Essex M, Janoff EN.
    J Infect Dis; 2007 Aug 15; 196(4):562-9. PubMed ID: 17624842
    [Abstract] [Full Text] [Related]

  • 16. Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults.
    Chen M, Ssali F, Mulungi M, Awio P, Yoshimine H, Kuroki R, Furumoto A, Tanimura S, Kityo C, Nagatake T, Mugyenyi P, Oishi K.
    Vaccine; 2008 Sep 08; 26(38):4962-8. PubMed ID: 18639599
    [Abstract] [Full Text] [Related]

  • 17. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.
    Lesprit P, Pédrono G, Molina JM, Goujard C, Girard PM, Sarrazin N, Katlama C, Yéni P, Morineau P, Delfraissy JF, Chêne G, Lévy Y, ANRS 114-Pneumovac Study Group.
    AIDS; 2007 Nov 30; 21(18):2425-34. PubMed ID: 18025879
    [Abstract] [Full Text] [Related]

  • 18. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response.
    Rodriguez-Barradas MC, Groover JE, Lacke CE, Gump DW, Lahart CJ, Pandey JP, Musher DM.
    J Infect Dis; 1996 Jun 30; 173(6):1347-53. PubMed ID: 8648206
    [Abstract] [Full Text] [Related]

  • 19. Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine.
    Miiro G, Kayhty H, Watera C, Tolmie H, Whitworth JA, Gilks CF, French N.
    J Infect Dis; 2005 Nov 15; 192(10):1801-5. PubMed ID: 16235180
    [Abstract] [Full Text] [Related]

  • 20. Immune response to capsular polysaccharide and surface proteins of Streptococcus pneumoniae in patients with invasive pneumococcal disease.
    Zysk G, Bethe G, Nau R, Koch D, Gräfin Von Bassewitz VC, Heinz HP, Reinert RR.
    J Infect Dis; 2003 Jan 15; 187(2):330-3. PubMed ID: 12552461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.